Stopping and Restarting GLP-1 Weight Loss Drugs May Reduce Their Effectiveness
Researchers at the Perelman School of Medicine at the University of Pennsylvania conducted a preclinical study examining the effects of inconsistent GLP-1 medication use, publishing their findings in the Journal of Clinical Investigation Insight. The study tested overweight mice that underwent cycles of stopping and restarting GLP-1 medications like Ozempic and Wegovy. Results showed that mice dropped progressively less weight with each subsequent cycle compared to their original weight loss, suggesting that inconsistent use may significantly reduce the drugs' effectiveness. The findings raise important questions about medication adherence patterns and long-term weight management strategies for patients using these increasingly popular weight-loss treatments.
Impact of Inconsistent GLP-1 Use on Weight Loss Effectiveness
▪Overweight mice dropped less and less weight with each cycle of stopping and restarting GLP-1 medications compared to their original weight-loss.
▪Inconsistent use of GLP-1 weight-loss medications like Ozempic and Wegovy may significantly lessen their effectiveness.
University of Pennsylvania Preclinical Study Findings
▪The Perelman School of Medicine at the University of Pennsylvania study tested the effects of stopping and restarting GLP-1 medications on overweight mice.
▪The Perelman School of Medicine at the University of Pennsylvania study on GLP-1 medications was published in the Journal of Clinical Investigation Insight.
▪Researchers at the Perelman School of Medicine at the University of Pennsylvania conducted a preclinical study on GLP-1 weight-loss medications.
Perspective of University of Pennsylvania researchers
▪University of Pennsylvania researchers' findings suggest that consistent medication adherence may be essential for maintaining GLP-1 weight loss drug effectiveness.
▪The University of Pennsylvania preclinical study demonstrates that repeated cycles of stopping and restarting GLP-1 medications produce diminishing weight loss returns in mice.
Story comments
Loading comments…